Diabetes Insights - Breakthroughs and Innovators

In this episode, Prof. Thomas Karagiannis and Dr Francesco Zaccardi take us behind the scenes of clinical guideline development at EASD. As methodologists involved in creating the first EASD clinical guidelines, they explain how rigorous evidence review, transparent processes and careful management of conflicts of interest help ensure recommendations are trustworthy and evidence-based.

The discussion explores the newly developed guideline on diabetes distress, upcoming guidance on continuous glucose monitoring in type 2 diabetes, and future recommendations on diabetes prevention. Along the way, Thomas and Francesco highlight the importance of patient involvement, the role of systematic reviews and meta-analyses, and the emerging opportunities for artificial intelligence in guideline development.

Join us for an insightful look at the work that transforms scientific evidence into practical recommendations that can shape diabetes care across Europe and beyond.

In this episode, Dame Melanie Davies and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on continuous glucose monitoring (CGM) in people living with type 2 diabetes.

As CGM becomes increasingly available, clinicians, researchers, and policymakers are seeking clear evidence-based guidance on its role in diabetes management. The discussion explores why CGM was selected as a priority topic, how guideline questions are developed, the importance of patient involvement, and the rigorous process used to evaluate clinical evidence.

The conversation also highlights the broader outcomes that matter to people living with diabetes (including quality of life, confidence and behaviour change) and examines how future recommendations could influence healthcare policy and access to diabetes technology across Europe and beyond.

In this episode, Prof. Eberhard Standl marks an extraordinary milestone - 50 years since attending his first EASD Congress. Looking back on a career spanning five decades, he shares how diabetes care has evolved from the challenges of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the potential reversal of type 2 diabetes.

Prof. Standl discusses the enduring importance of lifestyle interventions, the value of long-term partnerships between clinicians and people living with diabetes, and emerging research linking diabetes, obesity, metabolism, and cancer. He also reflects on the collaborative spirit of the diabetes research community and the exciting possibilities that lie ahead for both type 1 and type 2 diabetes.

In this episode, Prof. Richard Holt and Prof. Kirsten Nørgaard discuss the updated EASD-ADA Consensus Report on Type 1 Diabetes, a comprehensive update designed to provide timely, evidence-based guidance for healthcare professionals managing type 1 diabetes.

They explain how consensus reports differ from formal clinical guidelines, why they remain an important tool for advancing diabetes care, and how the latest update reflects major developments in diabetes technology and clinical practice since the original report was published in 2021.

The conversation explores stronger recommendations for continuous glucose monitoring (CGM) and automated insulin delivery systems, as well as new sections covering obesity management, diabetes-related complications, and cardiovascular risk factors. The speakers also discuss how consensus reports can influence healthcare policy, improve access to diabetes technologies, and support more consistent standards of care worldwide.

With the report currently open for public consultation, they highlight why feedback from the diabetes community is essential to shaping the final document and ensuring its relevance across diverse healthcare settings.

In this episode, Prof. Partha Kar joins EASD TV Host, Vivienne Parry, to explore the growing role of social media in healthcare and diabetes care.

From combating misinformation and amplifying patient voices to navigating online abuse and professional risks, Prof. Kar shares why he believes clinicians should engage - not retreat - from digital platforms. He discusses how social media helped shape conversations around continuous glucose monitoring (CGM) access in the UK, why visibility and accountability matter in healthcare leadership and how platforms like X, LinkedIn and Substack are changing the way research and medical information are shared.

The conversation also explores implementation science, global inequities in diabetes care and why translating research into real-world impact is one of healthcare’s biggest challenges.